194 related articles for article (PubMed ID: 36221229)
1. Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers.
McHenry S; Zong X; Shi M; Fritz CDL; Pedersen KS; Peterson LR; Lee JK; Fields RC; Davidson NO; Cao Y
Hepatol Commun; 2022 Dec; 6(12):3299-3310. PubMed ID: 36221229
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Souza M; Diaz I; Barchetta I; Mantovani A
Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
[TBL] [Abstract][Full Text] [Related]
3. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract][Full Text] [Related]
4. Increased Risk of Young-Onset Digestive Tract Cancers Among Young Adults Age 20-39 Years With Nonalcoholic Fatty Liver Disease: A Nationwide Cohort Study.
Park JH; Hong JY; Shen JJ; Han K; Park JO; Park YS; Lim HY
J Clin Oncol; 2023 Jun; 41(18):3363-3373. PubMed ID: 37075279
[TBL] [Abstract][Full Text] [Related]
5. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.
Allen AM; Hicks SB; Mara KC; Larson JJ; Therneau TM
J Hepatol; 2019 Dec; 71(6):1229-1236. PubMed ID: 31470068
[TBL] [Abstract][Full Text] [Related]
6. The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
Lee JM; Park YM; Yun JS; Ahn YB; Lee KM; Kim DB; Lee JM; Han K; Ko SH
PLoS One; 2020; 15(1):e0226351. PubMed ID: 31978054
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population-based study and review of literature.
Almomani A; Kumar P; Onwuzo S; Boustany A; Krishtopaytis E; Hitawala A; Alshaikh D; Albakri A; Hussein L; Hussein E; Asaad I
J Gastroenterol Hepatol; 2023 Feb; 38(2):269-273. PubMed ID: 36328950
[TBL] [Abstract][Full Text] [Related]
8. The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study.
Chen YG; Yang CW; Chung CH; Ho CL; Chen WL; Chien WC
Hepatol Int; 2022 Aug; 16(4):807-816. PubMed ID: 35064545
[TBL] [Abstract][Full Text] [Related]
9. Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China.
Wang Z; Zhao X; Chen S; Wang Y; Cao L; Liao W; Sun Y; Wang X; Zheng Y; Wu S; Wang L
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):788-796.e4. PubMed ID: 32407969
[TBL] [Abstract][Full Text] [Related]
10. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.
Simon TG; Roelstraete B; Khalili H; Hagström H; Ludvigsson JF
Gut; 2021 Jul; 70(7):1375-1382. PubMed ID: 33037056
[TBL] [Abstract][Full Text] [Related]
11. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.
Sanna C; Rosso C; Marietti M; Bugianesi E
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187365
[TBL] [Abstract][Full Text] [Related]
12. New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk.
Liu C; Liu T; Zhang Q; Jia P; Song M; Zhang Q; Ruan G; Ge Y; Lin S; Wang Z; Xie H; Shi J; Han R; Chen Y; Zheng X; Shen L; Deng L; Wu S; Shi H
JAMA Netw Open; 2023 Sep; 6(9):e2335511. PubMed ID: 37747732
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease.
Fan H; Zhang P; Liu Z; Zhao R; Suo C; Chen X; Zhang T
J Clin Transl Hepatol; 2023 Jun; 11(3):525-533. PubMed ID: 36969883
[TBL] [Abstract][Full Text] [Related]
14. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease.
Lyu J; Lin Q; Fang Z; Xu Z; Liu Z
Front Endocrinol (Lausanne); 2022; 13():1032557. PubMed ID: 36506064
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.
Mantovani A; Petracca G; Beatrice G; Csermely A; Tilg H; Byrne CD; Targher G
Gut; 2022 Apr; 71(4):778-788. PubMed ID: 33685968
[TBL] [Abstract][Full Text] [Related]
16. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
18. Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Rosso C; Caviglia GP; Birolo G; Armandi A; Pennisi G; Pelusi S; Younes R; Liguori A; Perez-Diaz-Del-Campo N; Nicolosi A; Govaere O; Castelnuovo G; Olivero A; Abate ML; Ribaldone DG; Fariselli P; Valenti L; Miele L; Petta S; Romero-Gomez M; Anstee QM; Bugianesi E
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3314-3321.e3. PubMed ID: 37149016
[TBL] [Abstract][Full Text] [Related]
19. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers.
Liu Z; Lin C; Suo C; Zhao R; Jin L; Zhang T; Chen X
Metabolism; 2022 Feb; 127():154955. PubMed ID: 34915036
[TBL] [Abstract][Full Text] [Related]
20. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
